The Neuroprotective Action of Amidated-Kyotorphin on Amyloid β Peptide-Induced Alzheimer's Disease Pathophysiology

• Main Authors: Rita F. Belo (Author), Margarida L. F. Martins (Author), Liana Shvachiy (Author), Tiago Costa-Coelho (Author), Carolina de Almeida-Borlido (Author), João Fonseca-Gomes (Author), Vera Neves (Author), Hugo Vicente Miranda (Author), Tiago F. Outeiro (Author), Joana E. Coelho (Author), Sara Xapelli (Author), Cláudia A. Valente (Author), Montserrat Heras (Author), Eduard Bardaji (Author), Miguel A. R. B. Castanho (Author), Maria José Diógenes (Author), Ana M. Sebastião (Author)
• Format: Book
• Published: Frontiers Media S.A., 2020-07-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Kyotorphin (KTP, l-tyrosyl-l-arginine) is an endogenous dipeptide initially described to have analgesic properties. Recently, KTP was suggested to be an endogenous neuroprotective agent, namely for Alzheimer's disease (AD). In fact, KTP levels were shown to be decreased in the cerebrospinal flu...